iCAD announces AI solutions to be offered in new MyBreastAI offering

iCAD (ICAD) announced that key artificial intelligence, AI, powered solutions from iCAD’s ProFound Breast Health Suite are the first applications to be offered in GE HealthCare’s (GEHC) new MyBreastAI Suite offering. “iCAD has been collaborating with GE HealthCare for more than 20 years and this latest offering is a powerful affirmation of our shared mission to advance breast health,” said Dana Brown, President and CEO of iCAD, Inc. “Our ProFound AI DBT technology is a cornerstone of AI-enabled solutions and is now offered as part of GE HealthCare’s MyBreastAI Suite to seamlessly deploy AI to breast imaging workflow to help enhance the detection and diagnosis of breast cancer while optimizing workflow efficiency to ultimately, help elevate patient care outcomes globally.” The first three AI applications to be offered as part of the initial release include the following solutions from iCAD: ProFound Detection, AI for Digital Breast Tomosynthesis; SecondLook for 2D Mammography; PowerLook Density Assessment;